Bayesian Capital Management’s SkinHealth Systems SKIN Stock Holding History

Bayesian Capital Management’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,938	Closed	-$19K	–	928
2024 Q4	$19K	Sell	11,938 -600	-5%	-$943	﹤0.01%	645
2024 Q3	$18.1K	Sell	12,538 -29,500	-70%	-$48.3K	﹤0.01%	640
2024 Q2	$80.7K	Sell	42,038 -75,200	-64%	-$212K	0.01%	658
2024 Q1	$521K	Buy	+117,238	New	+$381K	0.05%	425
2023 Q3	–	Sell	-10,000	Closed	-$83.7K	–	975
2023 Q2	$83.7K	Sell	10,000 -52,998	-84%	-$551K	0.01%	703
2023 Q1	$796K	Buy	+62,998	New	+$729K	0.1%	276
2022 Q2	–	Sell	-57,698	Closed	-$974K	–	1048
2022 Q1	$974K	Buy	+57,698	New	+$952K	0.15%	214

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Bayesian Capital Management's SKIN Position: Q1 2025 in Review

Bayesian Capital Management sold out of SkinHealth Systems (SKIN) in Q1 2025, closing a stake of 11,938 shares — an estimated $19K sold.

Bayesian Capital Management first reported a position in SKIN in Q1 2022 and held it in 7 quarters. The position peaked at $974K in Q1 2022. 97 funds tracked by Wall St. Rank hold SKIN as of Q1 2025.

Bayesian Capital Management reported no remaining SkinHealth Systems position as of Q1 2025 after selling out during the quarter.
Bayesian Capital Management sold 11,938 SkinHealth Systems shares in Q1 2025, an estimated $19K.
Bayesian Capital Management first reported a position in SkinHealth Systems in Q1 2022 and held it in 7 quarters.
Bayesian Capital Management's SkinHealth Systems position peaked at $974K in Q1 2022.
97 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.